Bluejay Diagnostics, Inc. (BJDX) shareholders
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 194,132 | 9.99% | 13G (passive) | Dec 31, 2025 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 142,728 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Waqas Khatri Joint filing with Ayrton Capital LLC (9.99%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (9.99%) | 107,722 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Mitchell P. Kopin Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%) | 0 | 9.99% | 13G (passive) | Jun 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BJDX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 131,000 | 2.93% | $157.20K | New | 0.00% |
| Heights Capital Management, Inc | 35,400 | 0.79% | $42.48K | New | 0.01% |
| Boothbay Fund Management, LLC | 27,130 | 0.61% | $32.56K | New | 0.00% |
| Bank Of America Corp /De/ | 10,337 | 0.23% | $12.40K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 10,225 | 0.23% | $12.27K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 1,907 | 0.04% | $2.29K | +178 | 0.00% |
| L1 Global Manager Pty Ltd | 120 | 0.00% | $144 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | 0.00% | $1 | −2 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 4.8% | 5 / 1 | 1 / 3 | 0M | 0M |
| Q1 2026 | 6 | 0M | 1.3% | 6 / 0 | 0 / 1 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held BJDX in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BJDX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 25,155 | 0.56% | $53.83K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 183 | 0.00% | $392 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Indranil Dey | President and CEO, Director | 40,649 | 0.91% | Aug 18, 2026 |
| Svetlana Dey | Director | 12,628 | 0.28% | Aug 18, 2026 |
| Douglas Clark Wurth | Director | 1,121,491 | 25.10% | Aug 18, 2026 |
| Fred S. Zeidman | Director | 12,500 | 0.28% | Aug 18, 2026 |
| Donald R. Chase | Director | 12,525 | 0.28% | Aug 18, 2026 |
| Bofa Securities, Inc. | 10% owner | 8 | 0.00% | Jul 22, 2026 |
| Of America Na Bank | 10% owner | – | – | Jul 22, 2026 |
| Of America Corp /De/ Bank | 10% owner | 8 | 0.00% | Jul 22, 2026 |
| Financial Lp Hrt | 10% owner | 92,055 | 2.06% | Jul 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Indranil Dey President and CEO, Director | Aug 17, 2026 | Award | +28,000 | – | – | 40,522 |
| Financial Lp Hrt 10% owner | Jul 10, 2026 | Sale | −34,938 | $1.40 | $48.91K | 92,055 |
| Financial Lp Hrt 10% owner | Jul 9, 2026 | Buy | +64,047 | $1.51 | $96.71K | 126,993 |
| Indranil Dey President and CEO, Director | Mar 14, 2026 | Buy | +12,500 | $2.00 | $25.00K | 12,522 |
| Douglas Clark Wurth Director | Mar 14, 2026 | Buy | +12,500 | $2.00 | $25.00K | 12,608 |
| Fred S. Zeidman Director | Mar 14, 2026 | Buy | +12,500 | $2.00 | $25.00K | 12,500 |
| Donald R. Chase Director | Mar 14, 2026 | Buy | +12,500 | $2.00 | $25.00K | 12,525 |
| Svetlana Dey Director | Mar 14, 2026 | Buy | +12,500 | $2.00 | $25.00K | 12,501 |
| Svetlana Dey Director | Dec 13, 2023 | Buy | +500 | $3.07 | $1.54K | 1,500 |
| Indranil Dey President and CEO, Director, 10% owner | Dec 13, 2023 | Buy | +500 | $3.27 | $1.64K | 28,526 |
| Indranil Dey President and CEO, Director | Mar 28, 2023 | Buy | +2,000 | $0.44 | $880 | 660,538 |
| Indranil Dey President and CEO, Director | Mar 28, 2023 | Award | +2,000 | $0.44 | $880 | 660,538 |
| Indranil Dey President and CEO, Director | Mar 27, 2023 | Buy | +8,000 | $0.44 | $3.52K | 558,538 |
| Indranil Dey President and CEO, Director | Mar 27, 2023 | Award | +8,000 | $0.44 | $3.52K | 558,538 |
| Svetlana Dey Director | Mar 24, 2023 | Buy | +10,000 | $0.44 | $4.40K | 47,500 |
| Svetlana Dey Director | Mar 24, 2023 | Award | +10,000 | $0.44 | $4.40K | 47,500 |
| Gary G. Gemignani Director | Feb 1, 2023 | Award | +27,500 | $0.44 | $12.10K | 27,500 |
| Svetlana Dey Director | Feb 1, 2023 | Award | +27,500 | $0.44 | $12.10K | 37,500 |
| Indranil Dey President and CEO, Director | Feb 1, 2023 | Tax withholding | −55,612 | $0.44 | $24.47K | 550,538 |
| Indranil Dey President and CEO, Director | Feb 1, 2023 | Award | +159,090 | $0.44 | $70.00K | 606,150 |
| Douglas Clark Wurth Director | Feb 1, 2023 | Award | +27,500 | $0.44 | $12.10K | 2,313,849 |
| Fred S. Zeidman Director | Feb 1, 2023 | Award | +27,500 | $0.44 | $12.10K | 27,500 |
| Kenneth R. Fisher Chief Financial Officer | Feb 1, 2023 | Tax withholding | −39,316 | $0.44 | $17.30K | 113,184 |
| Kenneth R. Fisher Chief Financial Officer | Feb 1, 2023 | Award | +112,500 | $0.44 | $49.50K | 152,500 |
| Donald R. Chase Director | Feb 1, 2023 | Award | +27,500 | $0.44 | $12.10K | 792,852 |
| Kenneth R. Fisher Chief Financial Officer | Aug 26, 2022 | Buy | +20,000 | $1.03 | $20.60K | 40,000 |
| Kenneth R. Fisher Chief Financial Officer | Apr 25, 2022 | Buy | +20,000 | $0.99 | $19.80K | 20,000 |
| Gordon Winston Kinder Chief Financial Officer | Mar 17, 2022 | Buy | +2,500 | $1.16 | $2.90K | 18,500 |
| Svetlana Dey Director, 10% owner | Mar 17, 2022 | Buy | +10,000 | $1.18 | $11.80K | 10,000 |
| Douglas Clark Wurth Director, 10% owner | Mar 17, 2022 | Buy | +40,000 | $1.18 | $47.20K | 2,286,349 |
| Douglas Clark Wurth Director, 10% owner | Mar 16, 2022 | Buy | +60,000 | $1.09 | $65.40K | 2,246,349 |
| Gordon Winston Kinder Chief Financial Officer | Mar 16, 2022 | Buy | +5,000 | $1.02 | $5.10K | 16,000 |
| Gordon Winston Kinder Chief Financial Officer | Mar 15, 2022 | Buy | +500 | $0.91 | $455 | 11,000 |
| Gordon Winston Kinder Chief Financial Officer | Mar 14, 2022 | Buy | +10,500 | $0.95 | $9.98K | 10,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bluejay Diagnostics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 189,599 shares on Sep 9, 2026 over the last 90 days.
See a number that looks wrong?